Key result
Co-detection of TTV, TTMV, and TTMDV in both pre-transplant and post-engraftment plasma specimens was documented in more than two-thirds of 25 allo-HSCT recipients.
Why the study?
Does monitoring of TTMV and TTMDV in addition to TTV improve the assessment of immune competence in allo-HSCT recipients?
Observational (n=25)
Does monitoring of TTMV and TTMDV in addition to TTV improve the assessment of immune competence in allo-HSCT recipients?
Co-detection of TTV, TTMV, and TTMDV is common in allo-HSCT recipients, suggesting that quantitative PCR for all three may better infer the net state of immunosuppression.
Anellovirus dynamics post-allo-HSCT remain hypothesis-generating; larger prospective studies needed before clinical immune monitoring use.
Monitoring of alphatorquevirus (torque teno virus [TTV]) DNA in plasma may prove to be useful to assess the net state of immune competence following allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are scarce data published on the prevalence of beta (torque teno mini virus [TTMV]) and gammatorqueviruses (torque teno midi virus [TTMDV]) and, in particular, on the dynamics of anelloviruses in allo-HSCT patients. Twenty-five allo-HSCT recipients with available plasma specimens obtained before conditioning and after engraftment were included. Degenerated primers targeting a highly conserved genomic sequence across all anelloviruses were designed for genomic amplification and high-throughput sequencing. Co-detection of TTV, TTMV, and TTMDV both in pre-transplant and post-engraftment plasma specimens was documented in more than two-thirds of patients. The use of quantitative real-time polymerase chain reaction (PCR) assays targeting TTMV and TTMDV in addition to TTV may add value to TTV-specific PCR assays in the inference of the net state of immunosuppresion or immune competence in this clinical setting.
No takes yet. Share an insight, caveat, or question.
Giménez et al. (2020) conducted an observational in allogeneic hematopoietic stem cell transplantation (allo-HSCT) (n=25). allogeneic hematopoietic stem cell transplantation was evaluated on Co-detection of TTV, TTMV, and TTMDV in pre-transplant and post-engraftment plasma specimens. Co-detection of TTV, TTMV, and TTMDV in both pre-transplant and post-engraftment plasma specimens was documented in more than two-thirds of 25 allo-HSCT recipients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: